These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15353483)

  • 1. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression.
    Tomoda K; Kato JY; Tatsumi E; Takahashi T; Matsuo Y; Yoneda-Kato N
    Blood; 2005 Jan; 105(2):775-83. PubMed ID: 15353483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex.
    Tomoda K; Kubota Y; Arata Y; Mori S; Maeda M; Tanaka T; Yoshida M; Yoneda-Kato N; Kato JY
    J Biol Chem; 2002 Jan; 277(3):2302-10. PubMed ID: 11704659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple functions of Jab1 are required for early embryonic development and growth potential in mice.
    Tomoda K; Yoneda-Kato N; Fukumoto A; Yamanaka S; Kato JY
    J Biol Chem; 2004 Oct; 279(41):43013-8. PubMed ID: 15299027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcr-Abl oncogene stimulates Jab1 expression via cooperative interaction of β-catenin and STAT1 in chronic myeloid leukemia cells.
    Yang KT; Wang MC; Chen JY; Hsu MC; Hung WC
    J Cell Physiol; 2011 Nov; 226(11):2849-56. PubMed ID: 21935931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAB1/CSN5 and the COP9 signalosome. A complex situation.
    Chamovitz DA; Segal D
    EMBO Rep; 2001 Feb; 2(2):96-101. PubMed ID: 11258719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines.
    Jonuleit T; van der Kuip H; Miething C; Michels H; Hallek M; Duyster J; Aulitzky WE
    Blood; 2000 Sep; 96(5):1933-9. PubMed ID: 10961897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway.
    Gesbert F; Sellers WR; Signoretti S; Loda M; Griffin JD
    J Biol Chem; 2000 Dec; 275(50):39223-30. PubMed ID: 11010972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A member of Forkhead transcription factor FKHRL1 is a downstream effector of STI571-induced cell cycle arrest in BCR-ABL-expressing cells.
    Komatsu N; Watanabe T; Uchida M; Mori M; Kirito K; Kikuchi S; Liu Q; Tauchi T; Miyazawa K; Endo H; Nagai T; Ozawa K
    J Biol Chem; 2003 Feb; 278(8):6411-9. PubMed ID: 12456669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
    Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
    Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells.
    Andreu EJ; Lledó E; Poch E; Ivorra C; Albero MP; Martínez-Climent JA; Montiel-Duarte C; Rifón J; Pérez-Calvo J; Arbona C; Prósper F; Pérez-Roger I
    Cancer Res; 2005 Apr; 65(8):3264-72. PubMed ID: 15833859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jab1 co-activation of c-Jun is abrogated by the serine 10-phosphorylated form of p27Kip1.
    Chopra S; Fernandez De Mattos S; Lam EW; Mann DJ
    J Biol Chem; 2002 Sep; 277(36):32413-6. PubMed ID: 12119282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
    Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
    Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The COP9 signalosome inhibits p27(kip1) degradation and impedes G1-S phase progression via deneddylation of SCF Cul1.
    Yang X; Menon S; Lykke-Andersen K; Tsuge T; Di Xiao ; Wang X; Rodriguez-Suarez RJ; Zhang H; Wei N
    Curr Biol; 2002 Apr; 12(8):667-72. PubMed ID: 11967155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation.
    Kim BC; Lee HJ; Park SH; Lee SR; Karpova TS; McNally JG; Felici A; Lee DK; Kim SJ
    Mol Cell Biol; 2004 Mar; 24(6):2251-62. PubMed ID: 14993265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gfer inhibits Jab1-mediated degradation of p27kip1 to restrict proliferation of hematopoietic stem cells.
    Teng EC; Todd LR; Ribar TJ; Lento W; Dimascio L; Means AR; Sankar U
    Mol Biol Cell; 2011 Apr; 22(8):1312-20. PubMed ID: 21346186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression.
    Parada Y; Banerji L; Glassford J; Lea NC; Collado M; Rivas C; Lewis JL; Gordon MY; Thomas NS; Lam EW
    J Biol Chem; 2001 Jun; 276(26):23572-80. PubMed ID: 11323429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tai Y; Tokuda M
    Clin Cancer Res; 2001 Dec; 7(12):4130-5. PubMed ID: 11751512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small Jab1-containing subcomplex is regulated in an anchorage- and cell cycle-dependent manner, which is abrogated by ras transformation.
    Fukumoto A; Tomoda K; Kubota M; Kato JY; Yoneda-Kato N
    FEBS Lett; 2005 Feb; 579(5):1047-54. PubMed ID: 15710389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclin-dependent kinase inhibitor p27/Kip1 and AP-1 coactivator p38/Jab1 correlates with differentiation of embryonal rhabdomyosarcoma.
    Tsuchida R; Miyauchi J; Shen L; Takagi M; Tsunematsu Y; Saeki M; Honna T; Yamada S; Teraoka H; Kato JY; Mizutani S
    Jpn J Cancer Res; 2002 Sep; 93(9):1000-6. PubMed ID: 12359053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
    Kouvaraki MA; Rassidakis GZ; Tian L; Kumar R; Kittas C; Claret FX
    Cancer Res; 2003 Jun; 63(11):2977-81. PubMed ID: 12782606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.